June 20, 2005
Hocus Crocus
Crocus failure should prompt greater disclosure
Aside from keeping the media busy, labour sponsored investment fund (LSIF)
Crocus Fund has caused a lot of grief for Manitoba investors. Its trading
freeze last December was followed by a flurry of terminations, big cost
cuts, allegations of wrong doing, and most recently the announcement that
they were throwing in the towel.
Does this mean investors should give up on LSIFs or venture capital as an
investment class? No. Rather, it should remind investors and advisors of
the need for real due diligence in alternative asset classes.
The lowdown
At the root of Crocus’ problems is the thorny issue of fairly valuing
investments not priced by or traded on any public exchange. (See my
previous
column on valuation from 2002.) Between the Manitoba
Securities
Commission and the Auditor
General of Manitoba, they allege that the
Valuation Committee (a subset of Crocus Fund’s board of directors) did not
meet for months while there were concerns voiced of deteriorating values.
There were also allegations of extravagant spending by the fund for its
former CEO on trips seemingly unrelated to Crocus business. Just prior to
the official launch
of a RCMP probe, Crocus made the only
obvious decision
– i.e. to either wind up the fund or dispose of its investments and other
assets to interested bidders.
This has taken a toll on the often beaten up class of LSIF investments.
But should all of this turn everyone off of LSIFs?
Due diligence
I have always stressed, even for traditional investments, how important it
is for investors and advisors to do their homework. But once investments
actually have had time to attempt to fulfill the big promises made during
sales presentations, and after a few good scandals – i.e. Portus,
Norshield,
Crocus – investors are likely to overreact. I’m not
going to
condone investing in things that are not well understood. But instead of
swearing off such investments forever, perhaps those burned by these or
other investments gone bad should simply learn what went wrong in the
decision-making process and if there are actions that can be done in the
future to help detect investment risks.
The fact is that there is no way to objectively confirm that LSIFs, hedge
funds, or other alternative asset investments actually do what they say
they do with respect to their investment processes and other internal
procedures. This has long been a point of frustration for me as an analyst
trying to evaluate some of these products.
With any investment, one must look past the hype, past the sales pitch and
all of the promised benefits. We all want to believe that a great
investment offering great risk-reward potential exists. And some do. But
investors and advisors would do themselves lots of favours if they
approached all such products with more scepticism and ask tough questions.
Plus, if you don’t really know how something is structured, refuse to
invest in it or recommend it to your clients. That will motivate the
person or company selling the product to help educate you on the aspects
of an investment not found in the sales pitch – i.e. the finer details
within which the devil often hides.
LSIF disclosure
In the mid-1990s, prior to the growth in LSIF assets, the funds used to
provide cost and market values for each individual investment. Today, and
for the past several years, funds provide individual cost figures but only
provide aggregate market value figures (i.e. for the venture portfolio as
a whole). As a result, we’re demanding better transparency for my firm’s
annual LSIF research report. One fund allowed us a peak at its internal
documents including investee company financials and due diligence
documents.
In my firm’s future LSIF
research efforts, we will continue to make
additional disclosures mandatory – or face being removed from our annual
survey. Realistically, investors aren’t in a big bargaining position to
demand such disclosure. But advisors influencing significant client money
have some pull – particularly with some of the small and mid-sized LSIFs.
Look for LSIFs to voluntarily provide additional portfolio disclosures –
as another fund did early this year. But if they don’t, advisors should
push for more information. No longer should they accept a negative
response to requests for greater disclosure. It is within advisors’ power
to influence greater LSIF disclosure. And while I believe that Crocus’
problems are not indicative of the LSIF industry as a whole, the very
existence of its demise provides us all with greater bargaining power
regarding improved disclosure.
Regulators will help a bit in this regard as CSA’s
National Instrument
81-106 (Continuous Disclosure) contains some tidbits for LSIFs. While
81-106 requires all funds, including LSIFs, to disclose market values for
individual investments, it offers LSIFs exemption. They can get out of
that requirement by breaking down its venture investments by stage of
development and industry class (and then by number of investments, cost,
and market value). This will help in narrowing down carrying or market
values that LSIFs use for their venture investments.
Recall that LSIFs must get an external valuator to review each investment.
LSIFs will now have to file the valuator’s report along with its audited
financials. It won’t contain valuations of individual investments in the
respective funds. But expect them to resemble the auditors’ reports that
accompany most funds’ audited financials. Most are pretty standard but
where the valuator has real concerns, it should be disclosed along with
other filings.
NI 81-106 doesn’t provide a quantum leap in LSIF disclosure, but it’s
certainly a step in the right direction.